| Gilead Sciences Switzerland Sàrl - AmBisome, Pulver zur Herstellung einer Infusionsdispersion |
| 53342 | | 01 | | AmBisome | | Pulver zur Herstellung einer Infusionsdispersion | | J02AA01 | | Amphotericin B | | 19.12.1996 | | |
|
| Composition |
| Praeparatio cryodesiccata: amphotericinum B 50 mg, phosphatidylcholinum ex soja hydrogenatum, cholesterolum, distearoylphosphatidylglycerolum natricum, int-rac-alpha-tocopherolum, saccharum, dinatrii succinas hexahydricus, acidum hydrochloridum, natrii hydroxidum, pro vitro corresp. natrium max. 8.5 mg. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | Pulver zur Herstellung einer Infusionsdispersion | | | | | | | | Active Agent | Dose |
|---|
| Amphotericinum B | 50 mg |
| | BAG: Active Agent | Dose |
|---|
| Amphotericinum b Liposomal | 50 mg |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum | | Cholesterol | | Dinatrii Succinas Hexahydricus | | Distearoylphosphatidylglycerolum Natricum | | Int-Rac-Alpha-Tocopherolum | | Sodium Hydroxide | | Phosphatidylcholinum ex soja Hydrogenatum | | Saccharum |
| |
|
|
